No abstract available.
Dermatitis, Atopic* ; Psoriasis*

No abstract available.
Hemangioma* ; Vulva*

No abstract available.
Adenoma* ; Toes*

No abstract available.
Lip

No abstract available.
Lip* ; Neurofibroma*

BACKGROUND: The incidence of scabies in Korea decreased during the past 20 years. This might have been due to improved personal hygiene and public sanitation. Recently, however, not only the incidence of scabies, but also delayed or missed diagnosis, is likely to increase again. OBJECTIVE: This study was conducted to obtain a better understanding of the clinical characteristics of recent scabietic patients. METHODS: We reviewed the medical records and clinical photographs of 27 outpatients who had been diagnosed with scabies in our department between August 2006 and August 2008. We investigated personal and clinical information, including age, sex, onset, past history and clinical manifestations. RESULTS: Of the 27 patients, 14 (51.9%) were female and 13 (48.1%) were male. Their ages ranged from 4 to 93 years (mean=47.2 years). Over half (51.9%) of the patients had been misdiagnosed at private hospitals. The average time from symptom presentation to diagnosis was 68 days. The most common site of skin lesions was the lower abdomen (77.8%), and the most common primary lesion was erythematous papules (96.3%). Atypical cases of scabies were as follows: 7 nodular scabies (25.9%), 1 crusted scabies (3.7%) and 4 scabies incognito (14.8%). CONCLUSION: Currently, atypical cases of scabies may be increasing and frequently misdiagnosed. We suggest that dermatologists should suspect scabies for any patient who presents with pruritus that is persistent or resistant to treatment.
Abdomen ; Female ; Hospitals, Private ; Humans ; Hygiene ; Incidence ; Korea ; Male ; Medical Records ; Outpatients ; Pruritus ; Sanitation ; Scabies ; Skin

Tinea incognito is a dermatophytosis of atypical clinical manifestation due to improper use of topical or systemic corticosteroids. We report two cases of tinea incognito misdiagnosed as eczema by non-dermatologist physicians. First, the lesions were manifested by pruritic, scaly localized erythematous macules and patches on the left ankle in a 61-year-old woman. She had been treated with topical steroids for 1 month without improvement. KOH smear revealed multiple fungal hyphae and histopathologic examination revealed the presence of fungal hyphae in the stratum corneum. Second, the lesions were manifested by localized scaly erythematous patches with pruritus on the face in a 76-year-old woman. She had been also treated with topical steroids for 2 months. KOH mount was positive for hyphae. All two patients were treated with 250 mg of terbinafine daily for 2 weeks and topical flutrimazole application. The lesions improved one month after treatment and no recurrence was observed.
Adrenal Cortex Hormones ; Aged ; Ankle ; Eczema* ; Female ; Humans ; Hyphae ; Middle Aged ; Pruritus ; Recurrence ; Steroids ; Tinea*

Erlotinib is a low-molecular-weight quinazoline derivative that inhibits the activation of epidermal growth factor receptor (EGFR) tyrosine kinase through competitive binding of the adenosine triphosphate binding domain of the receptor. Patients undergoing anti-EGFR therapy frequently present with cutaneous reactions like a sterile follicular and pustular rash, xerosis, pruritus, paronychia, hair abnormalities and mucositis, which can cause serious discomfort and negatively affect the compliance with anti-EGFR therapy. We report here on an interesting case of hair abnormalities induced by erlotinib (Tarceva(R)) and this presented as eyelash lengthening and hair curling in a 62-year-old woman.
Adenosine Triphosphate ; Binding, Competitive ; Compliance ; Exanthema ; Female ; Hair ; Humans ; Middle Aged ; Mucositis ; Paronychia ; Polyphosphates ; Protein-Tyrosine Kinases ; Pruritus ; Quinazolines ; Receptor, Epidermal Growth Factor ; Erlotinib Hydrochloride

Cystic lymphangioma is a true, benign, congenital multicystic tumor arising from sequestrations of embryonic lymphatic tissue. Most often it occurs at birth or during the early years of life, is found most commonly in the neck, and its distribution coincides with that of the primitive lymph sacs. A 23-year-woman presented with a soft palpable mass on her chest wall. Physical and ultrasound examination revealed a well-circumscribed, mobile, nontender, soft subcutaneous mass on the right posterior chest wall beneath the latissimus dorsi muscle. A skin biopsy of the mass showed endothelium-lined lymphatic vessels and a loose, lace-like fibrous tissue stroma. The specimen was stained with D2-40 showing positive staining of lymphatics. These histopathological findings confirmed the diagnosis of a cystic lymphangioma. We report a rare case of a cystic lymphangioma on the chest wall in a 23-year-old woman.
Adult* ; Biopsy ; Diagnosis ; Female ; Humans ; Lymphangioma, Cystic* ; Lymphatic Vessels ; Lymphoid Tissue ; Neck ; Parturition ; Skin ; Superficial Back Muscles ; Thoracic Wall* ; Thorax* ; Ultrasonography ; Young Adult

BACKGROUND: Cases of dermatitis induced by the injection of certain drugs have been reported. OBJECTIVE: The aim of this study was to assess the cause and clinicopathologic findings of injection-induced dermatitis, and to reveal whether the reaction has any relation to the patient's age, injection site, drug concentration, and time interval from the injection to the occurrence of the skin lesion. METHODS: In this study, we enrolled 10 patients who developed erythematous skin lesions after the injection of causative drugs. The lesions were compared to each other according to the injection site, time interval from the injection to the occurrence of the skin lesion, and clinical characteristics. We performed intradermal and patch tests in each patient with different concentrations of causative drugs. RESULTS: The most common causative drugs were diclofenac and vitamin K1. The eczematous type was the most frequent clinical type. The intradermal test showed more positive results than the patch test. The patch tests with diclofenac (as is, 2.5%, 5%, and 10%) and vitamin K1 (10%) were all negative in 10 patients. Furthermore, intradermal tests with diclofenac (as is) and vitamin K1 (0.1%, 1%, and 10%) were performed in 8 patients. Six patients had a positive reaction, consisting of erythema, induration, and vesiculation, after 1 and 2 days. CONCLUSION: Our results showed that the most common causative agents were diclofenac and vitamin K1. Moreover, it seems that that intradermal test is more useful than the patch test in the diagnosis of injection-induced dermatitis.
Dermatitis* ; Diagnosis ; Diclofenac ; Erythema ; Humans ; Intradermal Tests ; Patch Tests ; Skin ; Vitamin K ; Vitamin K 1